At the top of the list is our most recent review on the reproductive safety of psychotropic medications. Molenaar and colleagues look at the incidence of perinatal depression in women with pregravid histories of major [...]
There is a growing body of literature which indicates that anxiety symptoms are common during pregnancy and the postpartum period. Anxiety during pregnancy places the woman at greater risk for postpartum depression and may also [...]
We don’t hear this clinical question so often but it does come up from time to time. While the anticonvulsant oxcarbazepine (Trileptal) was initially promoted as a mood stabilizer for patients with bipolar disorder, it [...]
Peri- and post-menopausal women frequently complain of insomnia or poor sleep quality. Sleep disturbance is often attributed to nocturnal hot flashes; however, a study from researchers at Wayne State University School of Medicine suggests that [...]
While depression is a relatively common occurrence during the perinatal period, suicide is less common in pregnant and postpartum women than in other populations. Because suicide in this population is rare, we have limited information [...]
There have long been concerns regarding the safety of the anticonvulsant valproic acid (Depakote) during pregnancy. Back in 2009, the American Academy of Neurology and American Epilepsy Society recommended against the use of valproic acid [...]
Most women with depression experience considerable difficulty in making decisions about whether or not to use antidepressant medications during pregnancy. These decisions are very complex, and women must consider their own illness history and personal [...]
Since the the Food and Drug Administration (FDA) approved brexanolone as an intravenous infusion for the treatment of postpartum depression last week, we have been deluged with questions from patents, providers and the media regarding [...]
The excitement over the FDA approval of brexanolone (to be marketed as Zulresso) is a good place to start this week’s roundup. Brexanolone is a derivative of the neurosteroid allopregnanolone, and, while Zulpresso was approved [...]
Several weeks ago, the US Preventive Services Task Force (USPSTF) issued recommendations that all pregnant and postpartum women should be evaluated in order to determine risk for depressive illness and suggests that women at increased [...]